| Literature DB >> 27932618 |
Zenas George1, Yusuf Omosun1,2, Anthony A Azenabor3, James Partin1, Kahaliah Joseph1, Debra Ellerson1, Qing He1,2, Francis Eko2, Claudiu Bandea1, Pavel Svoboda1, Jan Pohl1, Carolyn M Black1, Joseph U Igietseme1.
Abstract
Chlamydia is an obligate intracellular bacterium that relies on host cells for essential nutrients and adenosine triphosphate (ATP) for a productive infection. Although the unfolded protein response (UPR) plays a major role in certain microbial infectivity, its role in chlamydial pathogenesis is unknown. We hypothesized that Chlamydia induces UPR and exploits it to upregulate host cell uptake and metabolism of glucose, production of ATP, phospholipids, and other molecules required for its replicative development and host survival. Using a combination of biochemical and pathway inhibition assays, we showed that the 3 UPR pathway transducers-protein kinase RNA-activated (PKR)-like ER kinase (PERK), inositol-requiring enzyme-1α (IRE1α), and activating transcription factor-6α (ATF6α)-were activated during Chlamydia infection. The kinase activity of PERK and ribonuclease (RNase) of IRE1α mediated the upregulation of hexokinase II and production of ATP via substrate-level phosphorylation. In addition, the activation of PERK and IRE1α promoted autophagy formation and apoptosis resistance for host survival. Moreover, the activation of IRE1α resulted in the generation of spliced X-box binding protein 1 (sXBP1) and upregulation of lipid production. The vital role of UPR pathways in Chlamydia development and pathogenesis could lead to the identification of potential molecular targets for therapeutics against Chlamydia. Published by Oxford University Press for the Infectious Diseases Society of America 2016. This work is written by (a) US Government employee(s) and is in the public domain in the US.Entities:
Keywords: Chlamydia; pathogenesis; unfolded protein response.
Mesh:
Substances:
Year: 2017 PMID: 27932618 PMCID: PMC6455037 DOI: 10.1093/infdis/jiw569
Source DB: PubMed Journal: J Infect Dis ISSN: 0022-1899 Impact factor: 5.226